Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival

Overview of attention for article published in World Journal of Surgical Oncology, November 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#38 of 2,100)
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

twitter: 4 X users
patent: 4 patents

f1000: 1 research highlight platform

Readers on

mendeley: 78 Mendeley

Summary X Patents Research highlights

So far, Altmetric has seen 4 patents that reference this research output.

THERAPEUTIC COMBINATIONS INCLUDING INHIBITORS OF THE P2X4 RECEPTOR FOR TREATING AND…

Application EP-4059495-A1

European Patent Office

Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging

Grant US-10736976-B2

United States of America

Anti-LGR5 antibodies and uses thereof

Application US-10316084-B2

United States of America

ANTI-LGR5 ANTIBODIES AND USES THEREOF

Application WO-2015191715-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.